[Articles] Oral treatment of Whipple’s disease with doxycycline and hydroxychloroquine versus intravenous therapy with ceftriaxone followed by oral trimethoprim–sulfamethoxazole in Germany: a phase 2/3, prospective, open-label, randomised, controlled, non-inferiority trial

Di |2025-02-18T00:30:01+01:00Febbraio 18th, 2025|Categorie: Coronavirus Lancet|

Oral-only treatment of Whipple's disease was safe and non-inferior to sequential intravenous–oral treatment. Oral treatment facilitates patient management and might reduce hospital-acquired treatment complications and costs.

[Articles] Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial

Di |2025-02-07T00:30:01+01:00Febbraio 7th, 2025|Categorie: Coronavirus Lancet|

The package of interventions consisting of pre-test and post-test tuberculosis counselling with conditional cash transfers significantly reduced the risk of unsuccessful tuberculosis patient outcomes, bringing one of the 90–90–90 targets within reach (...

[Review] Approaches to increase access to community-based infectious disease control for ethnically, racially, and religiously marginalised populations: a scoping review

Di |2025-02-06T00:30:05+01:00Febbraio 6th, 2025|Categorie: Coronavirus Lancet|

Marginalised populations often have reduced access to infectious disease prevention interventions, and as a result of this and other socioeconomic factors, these populations are at a higher risk of disease. Here, we reviewed the literature of community...

Torna in cima